China's top drug safety watchdog has said it has not found evidence of any ruptures in over 700 French-made breast implants sold in the country.
The implants produced by Poly Implant Prothese (PIP) have caused a global health scare after French authorities recently advised women in the country who carry such implants to have them removed over potential rupture risks.
The French medical regulatory agency said Dec 30 that 20 cancer cases were found in women wearing such implants, Xinhua reported.
An official inspection found that industrial-grade silicone was used in some of PIP's products without approval from health authorities.
China's State Food and Drug Administration (SFDA), in a probe of a China-based PIP sales agent, found that the company imported 912 such products after getting import approval from the SFDA in 2009.
A total of 743 PIP implants sold by the Chinese company have been traced in the country with no reports of ruptures.